@article{ATM5972,
author = {Kevin P. Daly},
title = {Circulating donor-derived cell-free DNA: a true biomarker for cardiac allograft rejection?},
journal = {Annals of Translational Medicine},
volume = {3},
number = {4},
year = {2015},
keywords = {},
abstract = {Heart transplantation remains a lifesaving therapy for adults and children with end-stage heart disease. Since the first heart transplant was performed in 1967, advances in peri-operative care and long term immunosuppression have dramatically improved post-transplant outcomes (1). Currently, adult recipients can expect a median allograft survival of greater than 10 years and infant recipients can expect a median allograft survival that is greater than 20 years (2,3).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/5972}
}